ATLASBiotechnology earnings calendar: upcoming and recent reports
475 Biotechnology companies report earnings over the next 45 days, led by Vertex Pharmaceuticals (VRTX), Moderna (MRNA) and Revolution Medicines (RVMD). 70 reported over the last 45 days; 64% of those with an EPS estimate came in above it and the average move around the report was 6.2%.
Source: company filings and exchange data · Updated Nov 2, 2026
Get this week’s earnings in your inbox every Monday
ATLAS Signals lists the biggest reports of the week, with ATLAS’s read on each, plus three stocks on our radar. One email, one-click unsubscribe.
ATLAS Signals
ATLAS Signals, every week
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy
Biotechnology: upcoming earnings (next 45 days)
| Company | Date | Time | EPS est. | ATLAS chance up (1 mo) | Likely range (50%) | Fair value vs price |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals VRTX · ATLAS page | Mon, Nov 2 | After close | $4.36 | 51% | $532.24 – $589.41 | $342.16 ($235.66–$414.19) · 63% above |
| Jazz Pharmaceuticals JAZZ · ATLAS page | Mon, Nov 2 | After close | -$5.18 | 51% | $205.10 – $228.26 | $488.98 ($354.62–$736.25) · 56% below |
| Summit Therapeutics SMMT · ATLAS page | Mon, Nov 2 | – | -$0.28 | 47% | $13.94 – $17.86 | – |
| BioMarin Pharmaceutical BMRN · ATLAS page | Mon, Nov 2 | After close | -$0.30 | 51% | $55.75 – $61.68 | – |
| Krystal Biotech KRYS · ATLAS page | Mon, Nov 2 | Before open | $1.84 | 50% | $311.77 – $354.23 | $297.56 ($207.55–$426.60) · 12% above |
| TG Therapeutics TGTX · ATLAS page | Mon, Nov 2 | Before open | $0.37 | 49% | $55.91 – $66.35 | $38.44 ($14.91–$98.11) · 59% above |
| Axsome Therapeutics AXSM · ATLAS page | Mon, Nov 2 | Before open | -$0.68 | 49% | $133.27 – $155.70 | – |
| Travere Therapeutics TVTX · ATLAS page | Mon, Nov 2 | After close | -$0.25 | 49% | $46.61 – $54.24 | $62.73 ($56.46–$69.01) · 20% below |
| Liquidia LQDA · ATLAS page | Mon, Nov 2 | – | $0.77 | 40% | $30.34 – $53.79 | $56.12 ($33.78–$93.23) · 20% below |
| Xenon Pharmaceuticals XENE · ATLAS page | Mon, Nov 2 | After close | -$1.17 | 47% | $33.26 – $41.22 | – |
| Madrigal Pharmaceuticals MDGL · ATLAS page | Tue, Nov 3 | Before open | -$1.09 | 50% | $402.13 – $460.08 | – |
| Vaxcyte PCVX · ATLAS page | Tue, Nov 3 | After close | -$1.84 | 47% | $54.12 – $69.01 | – |
| Spyre Therapeutics SYRE · ATLAS page | Tue, Nov 3 | After close | -$0.79 | 47% | $84.90 – $107.01 | – |
| ImmunityBio IBRX · ATLAS page | Tue, Nov 3 | Before open | -$0.08 | 46% | $7.05 – $9.33 | – |
| Corcept Therapeutics CORT · ATLAS page | Tue, Nov 3 | After close | $0.68 | 46% | $69.02 – $91.30 | $42.79 ($32.86–$57.60) · 90% above |
| Rhythm Pharmaceuticals RYTM · ATLAS page | Tue, Nov 3 | Before open | -$0.68 | 49% | $85.94 – $99.39 | – |
| Mirum Pharmaceuticals MIRM · ATLAS page | Tue, Nov 3 | After close | -$0.53 | 49% | $78.41 – $91.64 | – |
| Tango Therapeutics TNGX · ATLAS page | Tue, Nov 3 | – | -$0.34 | 45% | $19.07 – $25.72 | – |
| IDEAYA Biosciences IDYA · ATLAS page | Tue, Nov 3 | – | -$1.26 | 49% | $29.46 – $34.47 | – |
| Tarsus Pharmaceuticals TARS · ATLAS page | Tue, Nov 3 | After close | -$1.43 | 49% | $68.84 – $80.85 | $105.54 ($80.61–$138.17) · 29% below |
| Denali Therapeutics DNLI · ATLAS page | Tue, Nov 3 | After close | -$0.69 | 49% | $17.49 – $20.41 | – |
| Beam Therapeutics BEAM · ATLAS page | Tue, Nov 3 | Before open | -$1.17 | 46% | $23.59 – $30.40 | – |
| Aurinia Pharmaceuticals AUPH · ATLAS page | Tue, Nov 3 | – | $0.20 | 50% | $15.63 – $17.74 | $19.49 ($14.44–$26.30) · 15% below |
| Revolution Medicines RVMD · ATLAS page | Wed, Nov 4 | After close | -$2.34 | 49% | $175.87 – $206.72 | – |
| Royalty Pharma RPRX · ATLAS page | Wed, Nov 4 | Before open | $1.18 | 52% | $64.50 – $70.41 | $43.88 ($34.78–$54.80) · 53% above |
| Bio-Techne TECH · ATLAS page | Wed, Nov 4 | – | $0.40 | 53% | $70.47 – $75.54 | $29.61 ($21.37–$41.03) · 145% above |
| Caris Life Sciences CAI · ATLAS page | Wed, Nov 4 | After close | $0.03 | 48% | $30.69 – $37.71 | $14.80 ($11.58–$18.92) · 132% above |
| Cytokinetics CYTK · ATLAS page | Wed, Nov 4 | After close | -$1.50 | 50% | $59.11 – $67.15 | – |
| Ionis Pharmaceuticals IONS · ATLAS page | Wed, Nov 4 | Before open | -$1.22 | 50% | $40.59 – $46.59 | – |
| Dianthus Therapeutics DNTH · ATLAS page | Wed, Nov 4 | – | $1.00 | 48% | $75.01 – $89.54 | – |
| Arcutis Biotherapeutics ARQT · ATLAS page | Wed, Nov 4 | After close | $0.17 | 47% | $28.58 – $35.29 | $11.67 ($9.44–$14.64) · 175% above |
| Acadia Pharmaceuticals ACAD · ATLAS page | Wed, Nov 4 | After close | $0.19 | 49% | $19.03 – $22.18 | $35.74 ($30.41–$49.67) · 42% below |
| Dyne Therapeutics DYN · ATLAS page | Wed, Nov 4 | – | -$0.88 | 47% | $14.83 – $18.40 | – |
| Precigen PGEN · ATLAS page | Wed, Nov 4 | After close | $0.09 | 46% | $6.02 – $7.74 | – |
| Maravai LifeSciences MRVI · ATLAS page | Wed, Nov 4 | After close | -$0.07 | 46% | $6.71 – $8.75 | – |
| NewAmsterdam Pharma NAMS · ATLAS page | Wed, Nov 4 | Before open | -$0.50 | 48% | $18.10 – $21.92 | – |
| Recursion Pharmaceuticals RXRX · ATLAS page | Wed, Nov 4 | Before open | -$0.24 | 44% | $3.29 – $4.61 | – |
| Harmony Biosciences HRMY · ATLAS page | Wed, Nov 4 | Before open | $1.00 | 50% | $36.25 – $41.41 | – |
| Arcus Biosciences RCUS · ATLAS page | Wed, Nov 4 | After close | -$0.92 | 46% | $15.56 – $20.43 | – |
| Viridian Therapeutics VRDN · ATLAS page | Wed, Nov 4 | Before open | -$1.08 | 48% | $22.25 – $26.96 | – |
| ADMA Biologics ADMA · ATLAS page | Wed, Nov 4 | After close | $0.19 | 49% | $10.54 – $12.29 | $6.84 ($5.02–$9.56) · 67% above |
| Mineralys Therapeutics MLYS · ATLAS page | Wed, Nov 4 | After close | -$0.53 | 46% | $15.64 – $20.36 | – |
| Halozyme Therapeutics HALO · ATLAS page | Thu, Nov 5 | After close | $2.16 | 51% | $123.89 – $138.70 | $168.51 ($99.98–$284.03) · 22% below |
| Protagonist Therapeutics PTGX · ATLAS page | Thu, Nov 5 | After close | $2.58 | 50% | $135.27 – $154.91 | – |
| Definium Therapeutics DFTX · ATLAS page | Thu, Nov 5 | After close | -$0.55 | 48% | $32.47 – $39.91 | – |
| Edgewise Therapeutics EWTX · ATLAS page | Thu, Nov 5 | Before open | -$0.55 | 48% | $35.42 – $42.28 | – |
| Relay Therapeutics RLAY · ATLAS page | Thu, Nov 5 | After close | -$0.40 | 48% | $16.40 – $20.16 | – |
| Iovance Biotherapeutics IOVA · ATLAS page | Thu, Nov 5 | Before open | -$0.09 | 39% | $5.64 – $10.13 | – |
| Celcuity CELC · ATLAS page | Thu, Nov 5 | After close | -$1.47 | 48% | $62.23 – $75.65 | – |
| MBX Biosciences MBX · ATLAS page | Thu, Nov 5 | Before open | -$0.80 | 47% | $49.42 – $61.72 | – |
+425 more Biotechnology reports in this window; the table lists the largest by market value.
ATLAS columns: chance of a higher price in 1 month, the likely 1-month price range and the fair value with its range, from each company’s ATLAS page. They describe an ordinary period, not the earnings reaction.
Biotechnology: recent earnings results (last 45 days)
| Company | Date | Time | EPS est. | EPS reported | Surprise | Move* | ATLAS chance up (1 mo) | Likely range (50%) | Fair value vs price |
|---|---|---|---|---|---|---|---|---|---|
| Regeneron Pharmaceuticals REGN · ATLAS page | Fri, Oct 30 | – | $13.76 | $18.43 | +33.9% | – | 49% | $847.31 – $1,006.80 | $986.58 ($762.47–$1,276.58) · 6% below |
| Aurinia Pharmaceuticals AUPH · ATLAS page | Fri, Oct 30 | – | $0.22 | $0.23 | – | – | 50% | $15.63 – $17.74 | $19.49 ($14.44–$26.30) · 15% below |
| Vor Biopharma VOR · ATLAS page | Fri, Oct 30 | – | -$0.72 | -$0.90 | – | – | 47% | $17.19 – $21.88 | – |
| OmniAb OABI · ATLAS page | Fri, Oct 30 | – | -$0.12 | -$0.12 | 0.0% | – | 47% | $4.50 – $5.66 | – |
| NeOnc Technologies NTHI · ATLAS page | Fri, Oct 30 | – | $3.53 | $3.74 | – | – | 45% | $2.67 – $3.73 | – |
| ABVC Biopharma ABVC · ATLAS page | Fri, Oct 30 | – | – | -$0.05 | – | – | 46% | $0.86 – $1.12 | – |
| Cocrystal Pharma COCP · ATLAS page | Fri, Oct 30 | – | $3.53 | $3.74 | – | – | 48% | $0.91 – $1.09 | – |
| FibroBiologics FBLG · ATLAS page | Fri, Oct 30 | – | -$0.63 | -$2.60 | – | – | 45% | $0.78 – $1.05 | – |
| Alnylam Pharmaceuticals ALNY · ATLAS page | Thu, Oct 29 | – | $1.46 | $15.72 | +976.7% | – | 44% | $132.63 – $189.78 | $227.28 ($157.55–$327.88) · 27% below |
| Incyte INCY · ATLAS page | Thu, Oct 29 | – | -$4.27 | -$3.79 | +11.2% | – | 51% | $114.47 – $127.11 | $84.83 ($60.13–$119.69) · 42% above |
| Insmed INSM · ATLAS page | Thu, Oct 29 | – | -$0.34 | -$0.46 | -35.3% | – | 47% | $100.43 – $123.81 | – |
| Exelixis EXEL · ATLAS page | Thu, Oct 29 | – | $0.79 | $0.85 | +7.6% | – | 51% | $65.93 – $73.31 | $124.92 ($96.79–$161.22) · 44% below |
| BridgeBio Pharma BBIO · ATLAS page | Thu, Oct 29 | – | -$0.60 | -$0.42 | +30.0% | – | 49% | $69.08 – $80.86 | – |
| Kymera Therapeutics KYMR · ATLAS page | Thu, Oct 29 | – | -$1.26 | -$1.32 | -4.8% | – | 49% | $115.93 – $137.18 | – |
| Ligand Pharmaceuticals LGND · ATLAS page | Thu, Oct 29 | – | $1.42 | -$1.43 | -200.7% | – | 51% | $304.89 – $342.41 | – |
| PTC Therapeutics PTCT · ATLAS page | Thu, Oct 29 | – | $0.17 | $0.61 | +258.8% | – | 49% | $55.09 – $64.83 | $50.01 ($36.55–$68.43) · 20% above |
| Travere Therapeutics TVTX · ATLAS page | Thu, Oct 29 | – | -$0.25 | – | – | – | 49% | $46.61 – $54.24 | $62.73 ($56.46–$69.01) · 20% below |
| Fortrea FTRE · ATLAS page | Thu, Oct 29 | – | $0.24 | $0.28 | +16.7% | – | 47% | $18.59 – $23.68 | $23.44 ($16.81–$33.50) · 9% below |
| Biohaven BHVN · ATLAS page | Thu, Oct 29 | – | -$0.80 | -$0.86 | -7.5% | – | 45% | $12.63 – $17.62 | – |
| Stoke Therapeutics STOK · ATLAS page | Thu, Oct 29 | – | -$0.88 | -$1.08 | -22.7% | – | 48% | $23.72 – $28.73 | – |
| Ardelyx ARDX · ATLAS page | Thu, Oct 29 | – | -$0.03 | – | – | – | 49% | $2.77 – $3.28 | – |
| Phathom Pharmaceuticals PHAT · ATLAS page | Thu, Oct 29 | – | -$0.01 | -$0.03 | -200.0% | – | 45% | $4.80 – $6.50 | – |
| Contineum Therapeutics CTNM · ATLAS page | Thu, Oct 29 | – | -$0.45 | -$0.45 | – | – | 42% | $7.12 – $10.98 | – |
| Immuneering IMRX · ATLAS page | Thu, Oct 29 | – | -$0.29 | -$0.37 | -27.6% | – | 47% | $3.29 – $4.16 | – |
| INmune Bio INMB · ATLAS page | Thu, Oct 29 | – | -$0.18 | -$0.24 | – | – | 46% | $1.26 – $1.62 | – |
| Cerenome CNSY · ATLAS page | Thu, Oct 29 | – | -$0.98 | $1.00 | – | – | 45% | $1.43 – $1.92 | – |
| Pulmatrix PULM · ATLAS page | Thu, Oct 29 | – | – | -$0.24 | – | – | 47% | $1.23 – $1.56 | – |
| Viking Therapeutics VKTX · ATLAS page | Wed, Oct 28 | – | $1.00 | -$1.55 | -255.0% | – | 46% | $23.30 – $30.65 | – |
| Replimune Group REPL · ATLAS page | Wed, Oct 28 | – | -$0.70 | -$0.54 | +22.9% | – | 44% | $14.16 – $20.25 | – |
| MiMedx Group MDXG · ATLAS page | Wed, Oct 28 | – | – | -$0.01 | – | – | 48% | $3.54 – $4.21 | $7.14 ($4.42–$11.52) · 46% below |
| Vanda Pharmaceuticals VNDA · ATLAS page | Wed, Oct 28 | – | -$0.72 | -$0.37 | +48.6% | – | 49% | $3.49 – $4.09 | – |
| LENZ Therapeutics LENZ · ATLAS page | Wed, Oct 28 | – | -$0.97 | -$0.99 | -2.1% | – | 46% | $2.61 – $3.43 | – |
| BriaCell Therapeutics BCTX · ATLAS page | Wed, Oct 28 | – | – | -$1.24 | – | – | 46% | $2.63 – $3.40 | – |
| Immunovant IMVT · ATLAS page | Tue, Oct 27 | – | $2.24 | $2.46 | +9.8% | +4.4% | 49% | $27.04 – $31.35 | – |
| Arcutis Biotherapeutics ARQT · ATLAS page | Tue, Oct 27 | – | $0.17 | – | -100.0% | -1.1% | 47% | $28.58 – $35.29 | $11.67 ($9.44–$14.64) · 175% above |
| Arcus Biosciences RCUS · ATLAS page | Tue, Oct 27 | – | -$0.92 | – | +100.0% | +3.6% | 46% | $15.56 – $20.43 | – |
| Septerna SEPN · ATLAS page | Tue, Oct 27 | – | $0.83 | $0.88 | +6.0% | +6.9% | 48% | $39.46 – $48.25 | $93.21 ($73.13–$121.71) · 53% below |
| Pharming Group N.V. ADR PHAR · ATLAS page | Tue, Oct 27 | – | $0.33 | $0.30 | -9.1% | +3.0% | 48% | $10.95 – $13.43 | $10.96 ($9.87–$12.06) · 12% above |
| Wave Life Sciences WVE · ATLAS page | Tue, Oct 27 | – | -$0.34 | -$0.30 | +11.8% | +13.4% | 47% | $3.18 – $3.97 | – |
| Zura Bio ZURA · ATLAS page | Tue, Oct 27 | – | -$0.22 | -$0.20 | +9.1% | +22.2% | 44% | $3.22 – $4.66 | – |
30 more reported in this window.
ATLAS columns: chance of a higher price in 1 month, the likely 1-month price range and the fair value with its range, from each company’s ATLAS page. They describe an ordinary period, not the earnings reaction.
*Move: change in the closing price from the last close before the report day to the close the day after it.
Largest Biotechnology companies and their next report
- Vertex Pharmaceuticals (VRTX) · Nov 2
- Moderna (MRNA) · Nov 6
- Regeneron Pharmaceuticals (REGN)
- Revolution Medicines (RVMD) · Nov 4
- Royalty Pharma (RPRX) · Nov 4
- Alnylam Pharmaceuticals (ALNY)
- Roivant Sciences (ROIV) · Nov 9
- Incyte (INCY)
- Insmed (INSM)
- Ascendis Pharma A/S (ASND) · Nov 11
- Exelixis (EXEL)
- Halozyme Therapeutics (HALO) · Nov 5
- Jazz Pharmaceuticals (JAZZ) · Nov 2
- BridgeBio Pharma (BBIO)
- Summit Therapeutics (SMMT) · Nov 2
- Bio-Techne (TECH) · Nov 4
- BioMarin Pharmaceutical (BMRN) · Nov 2
- Kymera Therapeutics (KYMR)
- Twist Bioscience (TWST) · Nov 12
- Madrigal Pharmaceuticals (MDGL) · Nov 3
- Krystal Biotech (KRYS) · Nov 2
- Vaxcyte (PCVX) · Nov 3
- Caris Life Sciences (CAI) · Nov 4
- Protagonist Therapeutics (PTGX) · Nov 5
- TG Therapeutics (TGTX) · Nov 2
- Spyre Therapeutics (SYRE) · Nov 3
- ImmunityBio (IBRX) · Nov 3
- Corcept Therapeutics (CORT) · Nov 3
- Cytokinetics (CYTK) · Nov 4
- Arrowhead Pharmaceuticals (ARWR) · Nov 24
- Praxis Precision Medicines (PRAX) · Nov 9
- Axsome Therapeutics (AXSM) · Nov 2
- Ionis Pharmaceuticals (IONS) · Nov 4
- Rhythm Pharmaceuticals (RYTM) · Nov 3
- Oruka Therapeutics (ORKA) · Nov 11
- Ligand Pharmaceuticals (LGND)
Earnings calendar: frequently asked questions
Which Biotechnology companies report earnings soon?
Vertex Pharmaceuticals (VRTX), Moderna (MRNA), Revolution Medicines (RVMD), Royalty Pharma (RPRX), Roivant Sciences (ROIV) and Ascendis Pharma A/S (ASND) are among the largest Biotechnology reports scheduled in the next 45 days. 475 are listed with a confirmed date.
How many Biotechnology companies beat EPS estimates?
Of the 58 Biotechnology companies that reported over the last 45 days with an EPS estimate on record, 37 (64%) reported EPS above the estimate. That is a snapshot of one window, not a forecast.
Where do these Biotechnology dates come from?
Dates are confirmed report dates from company and exchange data, refreshed daily. Estimated dates are never shown here; only individual company pages show an ATLAS estimate, clearly labelled.
What is the difference between before the open and after the close?
Reports released before the open (BMO) move the stock in that same session. Reports released after the close (AMC) are first reflected the next trading day. ATLAS shows the time when the exchange data provides it.
Other industries
- Full US earnings calendar
- Banks - Regional earnings
- Software - Application earnings
- Software - Infrastructure earnings
- Medical Devices earnings
- Asset Management earnings
- Aerospace & Defense earnings
- Capital Markets earnings
- Drug Manufacturers - Specialty & Generic earnings
- Specialty Industrial Machinery earnings
- Information Technology Services earnings
- Oil & Gas E&P earnings
- Semiconductors earnings
Open any company page to set an email alert for its next report. Looking for a single stock? Try Apple (AAPL).
Educational information, not investment advice. Disclaimer